Why Attend?
CPI is planned for nurses by nurses…
Relevant
The APNA Clinical Psychopharmacology Institute (CPI) presents a state-of-the-science understanding of psychopharmacologic and non-psychopharmacologic approaches for nursing practice across the lifespan. The Institute focuses on complex clinical issues, addressing the most current practices and insights in clinical psychopharmacology.
Unique PMHN POV
The complexity of unique illness states or populations requires unique approaches that are more personal and consider the context and environments of persons you serve. CPI is unique in that it is a tailored specifically for psychiatric-mental health nurses by those who know their needs best – psychiatric-mental health nurses themselves.
Beyond Medication to Person-centered Care
The program goes beyond presenting medication algorithms and instead offers the scientific base from which treatment decisions are made, while also addressing aspects informing the context of care within the nurse/consumer/family relationship.
“Every session had something that I can apply to my practice. The expert presenters elevated our thinking and awareness of new treatment possibilities! ”
– 2025 CPI attendee
You will benefit from…
- Earn up to 30.25 contact hours in pharmacology in-person or virtually. Start learning and earning contact hours right away with regular confernce registration.
- Enjoy your library of online session recordings for a full year. Earn contact hours for what you did not attend! (Available 1-2 months afterwards)
- Opportunities to network and enjoy your PMH nursing community
- Digital session handouts with resources and references to explore
- Connect with industry stakeholders who value the work of PMH nurses
You will get in-depth education on…
- Strategies to alter the long-term trajectory of bipolar disorder.
- The course and treatment of psychiatric illness during pregnancy
- Stage-based care to improve the clinical outcome of schizophrenia
- Updates in the diagnosis and treatment of neurocognitive disorders such as Alzheimer’s disease, Parkinson’s disease, Lewy Body disease, and vascular dementia
- Varenicline and other smoking cessation treatments, plus an overview of the state of vaping and other nicotine delivery methods.
- Legal pitfalls in psychopharmacology and prescribing, as well as documentation best practices to help you protect your license.
